AVIR Message Board Post 9196020 | Atea Pharmaceuticals Inc.
home / stock / avir / avir message board
Chyland
(investorshub)
Posted on: Feb/28/2023 21:25:11
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171323550
$AVIR 4Q22 results12/31/22 cash=$647M:
News, Short Squeeze, Breakout and More Instantly...
Atea Pharmaceuticals Inc. Company Name:
AVIR Stock Symbol:
Market:
-
Atea Pharmaceuticals Inc (NASDAQ:AVIR) announced Wednesday new data from the lead-in cohort (n=60) of the company’s ongoing Phase 2 combinati...
-
97% SVR12 Rate Observed with 8 Weeks of Treatment in Lead-In Cohort of HCV-Infected Patients in Ongoing Phase 2 Clinical Study EASL Presentations Continue to Support Best-in-Class Potential with High Antiviral Potency, Short Treatment Duration, Low Risk of Drug Interaction and High Barr...
-
Presentations to Include New Antiviral Efficacy Results, Including SVR12 Data, from Lead-In Cohort of Ongoing Phase 2 HCV Trial Data Also Highligh...